"An intraurethral prosthesis that compensates for impaired detrusor function by emptying the bladder via an activator."
A device that lets women with urinary retention empty their bladder naturally again, no catheter. Restoring function and dignity.
Vesiflo makes the inFlow, an intraurethral prosthesis that restores natural bladder function for women living with urinary retention, a real answer to a problem still managed with catheters. For a pre-funding raise, founder Kevin needed an investor deck. The story was genuinely compelling, life-changing for patients, but the deck read like a clinical document: purple rule-bars, confidential stamps, dense medical text. We rebuilt it clean and modern in Vesiflo blue, so the unmet need, the patient voice and the business all land.
A life-changing device, real patient voices, genuine physician demand, and slides that looked like a regulatory filing. Purple rule-bars across every header, "Strictly private & confidential" stamps, paragraphs of clinical language. Investors could read the facts. They just could not feel the dignity the device gives back.




Real slides from the original deck, formatted like a clinical document.
No template, no quick reskin. The same partnership we bring to every founder: strategy first, then design, then motion. The rest of this page is those three moves, in order.
We started with a working session, not a design tool. We led with the unmet need and the patient voice, women still living on catheters, the inFlow called "life-changing", then let the clinical proof and the business follow.
A clean, modern system in Vesiflo blue, real patient and clinical imagery, generous white space, so every slide carries one idea with warmth. The purple rule-bars and confidential clutter gave way to a calm, credible medtech look.
Strategic animation so each point builds on cue as Kevin presents, pause, click, and the next idea lands. A dynamic version for the room and a clean static PDF for investors in advance. Delivered in PowerPoint and PDF.
The deck opened with mechanism and medical detail. But what makes investors lean in is the human story: people getting their lives back. We did not touch the science, we just put the patient first and let the clinical evidence prove the point.
"An intraurethral prosthesis that compensates for impaired detrusor function by emptying the bladder via an activator."
A device that lets women with urinary retention empty their bladder naturally again, no catheter. Restoring function and dignity.
Patient testimonials sat several slides deep, in small text under the clinical detail.
"Life-changing." The patient voice given its own slide, early, where it sets the stakes for everything that follows.
Here are the real slides, before and after. The purple-barred clinical document becomes clean Vesiflo blue: one idea, room to breathe, and real people instead of rule-lines and confidential stamps.


The unmet need. A wall of clinical text becomes one clear, human point.


The new option. The inFlow gets the clean, confident introduction it deserves.


The patient voice. "Life-changing" finally gets the space it deserves.
A single clean palette in Vesiflo blue, no rule-bars, no stamps, just clarity. Deep navy to anchor it, a clinical blue to guide the eye, soft tints and real photography so a sensitive subject is handled with the dignity it deserves.
Kevin sends the deck to investors in advance, then presents it live. So we built it both ways: a clean static PDF that reads on its own, and a dynamic version where each point builds on cue as he talks. Below, the redesigned deck in motion.








If your device changes lives but the deck reads like a filing, that is the gap we close. Messaging, clean design and strategic animation, so the human story lands and the evidence backs it up.